Core Insights - Adient reported 3.56billioninrevenueforthequarterendedSeptember2024,ayear−over−yeardeclineof4.50.68 compared to 0.51ayearago[1]−TherevenueexceededtheZacksConsensusEstimateof3.48 billion, resulting in a surprise of +2.25%, while the EPS also surpassed expectations by +21.43% [1] Revenue Performance by Region - Net Sales in Asia reached 765million,exceedingtheestimated715.33 million, reflecting a year-over-year increase of +2.3% [3] - Net Sales in the Americas were reported at 1.72billion,slightlybelowtheaverageestimateof1.74 billion, indicating a year-over-year decline of -6.3% [3] - Net Sales in EMEA amounted to 1.10billion,surpassingtheestimated1.07 billion, but showing a year-over-year decrease of -6.1% [3] - Net Sales from Eliminations were reported at -25million,worsethantheestimated−23.63 million, representing a year-over-year change of -10.7% [3] Stock Performance - Adient's shares have returned -9.1% over the past month, contrasting with the Zacks S&P 500 composite's +4.9% change [4] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [4]